The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Korenberg Matthew E since year 2005.
The trader's CIK number is 1649903.
At the time of the last reporting, Korenberg Matthew E was the EVP,Finance & Strategy and CFO of Ligand Pharmaceuticals Inc .
(stock ticker symbol LGND).
See this page for all insider trading activities at Ligand Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-09-03||LGND||Ligand Pharmaceuticals Inc||Buy||500||86.18||43,091|
|2018-08-29||LGND||Ligand Pharmaceuticals Inc||Option Ex||11,540||85.79||990,016|
|2018-08-29||LGND||Ligand Pharmaceuticals Inc||Sale||18,357||256.69||4,712,058|
|2017-11-17||LGND||Ligand Pharmaceuticals Inc||Sale||6,559||142.63||935,510|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Korenberg Matthew E (EVP,Finance & Strategy and CFO of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.